Page 1 of Clinical Trials for metastatic, 15321 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
Last Updated: March 14, 2012
Condition(s): Metastatic Melanoma; Metastatic Renal Cancer
2
Completed
Aldesleukin in Patients With Metastatic Renal Cell Carcinoma and Metastatic Melanoma
Last Updated: April 27, 2012
Condition(s): Metastatic Renal Cell Carcinoma; Metastatic Melanoma
3
Active, not recruiting
MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC)
Last Updated: January 5, 2012
Condition(s): Metastatic Colorectal Cancer
4
Suspended
MAGE-A3/12 Metastatic Cancer Treatment With Anti-MAGE-A3/12 TCR-Gene Engineered Lymphocytes
Last Updated: March 14, 2012
Condition(s): Metastatic Cancer; Metastatic Renal Cancer; Metastatic Melanoma
5
Not yet recruiting
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohorts in KRAS Wild Type Metastatic Colorectal and Pancreatic Cancer
Last Updated: April 2, 2012
Condition(s): Advanced Solid Tumors; Metastatic Colorectal Cancer; Metastatic Pancreatic Cancer
6
Suspended
Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer
Last Updated: March 14, 2012
Condition(s): Metastatic Cancer; Metastatic Melanoma; Metastatic Renal Cancer
7
Recruiting
Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
Last Updated: July 5, 2011
Condition(s): Metastatic Breast Cancer
8
Active, not recruiting
Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
Last Updated: June 16, 2011
Condition(s): Metastatic Breast Cancer; Lung Cancer
9
Not yet recruiting
Phase I Study of Cabazitaxel, Mitoxantrone, and Prednisone (CAMP) for Patients With Metastatic Castration-Resistant Prostate Cancer and no Prior Chemotherapy
Last Updated: May 7, 2012
Condition(s): Metastatic Castration-resistant Prostate Cancer
10
Recruiting
Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression
Last Updated: November 14, 2011
Condition(s): Metastatic Epidural Spinal Cord Compression
11
Completed
Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma
Last Updated: August 24, 2009
Condition(s): Metastatic Renal Cell Carcinoma; Metastatic Malignant Melanoma
12
Recruiting
A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
Last Updated: September 13, 2011
Condition(s): Metastatic Pancreatic Cancer
13
Recruiting
Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
Last Updated: December 28, 2011
Condition(s): Metastatic Renal Cell Carcinoma
14
Recruiting
Treating Metastatic Cancer With Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes
Last Updated: March 14, 2012
Condition(s): Metastatic Cancer; Metastatic Melanoma; Renal Cancer
15
Completed
Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
Last Updated: May 26, 2011
Condition(s): Carcinoma, Metastatic Breast
16
Recruiting
Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
Last Updated: October 17, 2011
Condition(s): Metastatic Breast Cancer
17
Active, not recruiting
Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
Last Updated: January 3, 2012
Condition(s): Metastatic Colorectal Cancer
18
Active, not recruiting
Abiraterone Acetate Plus Prednisone Drug-Drug Interaction With Dextromethorphan and Theophylline Treating Metastatic Castration-Resistant Prostate Cancer
Last Updated: April 6, 2012
Condition(s): Metastatic Castration-Resistant Prostate Cancer
19
Completed
Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)
Last Updated: January 13, 2010
Condition(s): Neuroendocrine Tumors; Metastatic Neuroendocrine Tumors
20
Active, not recruiting
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma
Last Updated: October 5, 2009
Condition(s): Metastatic Renal Cell Carcinoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=metastatic

Page 1 of Clinical Trials for metastatic, 15321 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About